Overexpression of WNT2 and TSG101 genes in colorectal Carcinoma

Tropical Biomedicine

Volumn 25, Issue 1, 2008, Pages 46-57

  Ru, Ma Xiang ^a   Hang, Edmund Sim Ui ^a   Balraj, Pauline ^b   Lim, Patricia ^c   Jamal, Rahman ^d  

^a Faculty of Computer Science and Information Technology   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; WNT2 PROTEIN; WNT2 PROTEIN, HUMAN;

ARTICLE; BIOPSY; COLON; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BIOPSY; COLON; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; UP-REGULATION; WNT2 PROTEIN;

EID: 70149115772     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Balz, V., Prisack, H.B., Bier, H. & Bojar, H. (2002). Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families. Cancer Genetics and Cytogenetics 138: 120-127.
2. Bienz, M. & Clevers, H. (2000). Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
3. Carney, M.E., Maxwell, G.L., Lancaster, J. M., Gumbs, C., Marks, J., Berchuck, A. & Futreal, P.A. (1998). Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers. Journal of Society for Gynecologic Investigation 5: 281-285.
4. Fearon, E.R. & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
5. Hampl, M., Hampl, J., Plaschke, J., Fitze, G., Schackert, G., Saeger, H.D. & Schackert, H.K. (1998). Evidence that TSG101 aberrant transcripts are PCR artifacts. Biochemical and Biophysical Research Communications 248: 753-760.
6. Holcombe, R.F., Marsh, J.L., Waterman, M.L., Lin, F., Milovanovic, T. & Truong, T. (2002). Expression of Wnt ligands and frizzled receptors in colonic mucosa and in colon carcinoma. Journal of Clinical Pathology 55: 220-226.
7. Katoh, M. (2001). Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. International Journal of Oncology 19: 1003-1007.
8. Kinzler, K.W. & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.
9. Lanza, G., Matteuzzi, M., Gafa, R., Orvieto, E., Maestri, I., Santini, A. & del Senno, L. (1998). Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. International Journal of Cancer 79: 390-395.
10. Li, L., Li, X., Francke, U. & Cohen, S.N. (1997). The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88: 143-154.
11. Li, L., Liao, J., Ruland, J., Mak, T.W. & Cohen, S.N. (2001). A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. PNAS 98: 1619-1624.
12. Liu, R.T., Huang, C.C., You, H.L., Chou, F.F., Hu, C.C.A., Chao, F.P., Chen, C.M. & Cheng, J.T. (2002). Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas. Oncogene 21: 4830-4837.
13. Miller, J.R. (2001). The Wnts. Genome Biology 3: 3001.1-3001.15.
14. Ogunbiyi, O.A., Goodfellow, P.J., Herfarth, K., Gagliardi, G., Swanson, P.E., Birnbaum, E.H., Read, T.E., Fleshman, J.W., Kodner, I.J. & Moley, J.F. (1998). Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. Journal of Clinical Oncology 16: 427-433.
15. Renkonen, E., Zhang, Y., Lohi, H., Salovaara, R., Abdel-Rahman, W.M., Nilbert, M., Aittomaki, K., Jarvinen, H.J., Mecklin, J.P., Lindblom, A. & Peltomaki, P. (2003). Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology 21: 3629-3637.
16. Ruland, J., Sirard, C., Elia, A., MacPherson, D., Wakeham, A., Li. L., Pompa, J.L.D.L., Cohen, S.N. & Mak, T.W. (2000). P53 early accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. PNAS 98: 1859-1864.
17. Sim, E.U.H., Bong, I.P.N., Balraj, P., Tan, S.K., Jamal, R., Sagap, I., Nadeson, S., Rose, I.M. & Lim, P.K.M. (2006). A preliminary study of differentially expressed genes in Malaysian Colorectal Carcinoma Cases. Journal of Bioscience 17(1): 27- 45.
18. Turpin, E., Dalle, B. de Roquancourt, A., Plassa, L.F., Marty, M. Janin, A., Beuzard, Y., de The, H. (1999). Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers. Oncogene 18: 7834-7837.
19. Vider, B.Z., Zimber, A., Chastre, E., Prevot, S., Gespach, C., Estlein, D., Wolloch, Y., Tronick, S.R., Gazit, A. & Yaniv, A. (1996). Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 12: 153-158.
20. Wagner, K.U., Krempler, A., Qi, Y., Park, K.R., Henry, M.L.D., Triplett, A.A., Riedlinger, G., Rucker III, E.B. & Hennighausen, L. (2003). Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Molecular and Cellular Biology 23: 150- 162.
21. Xie, W., Li, L. & Cohen, S.N. (1998). Cell cycledependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency. PNAS 95: 1595-1600.
22. You, Z., Saims, D., Chen, S., Zhang, Z., Guttridge, D.C., Guan, K., MacDougald, O.A., Brown, A.M.C., Evan, G., Kitajewski, J. & Wang, C.Y. (2002). Wnt signaling promotes oncogenic transformation by inhibiting c-Mycinduced apoptosis. The Journal of Cell Biology 157: 429-440.
23. Young, T.W., Mei, F.C., Rosen, D.G., Yang, G., Li, N., Liu, J. & Cheng, X. (2007). Up regulation of tumour susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses. Molecular & Cellular Proteomics 6: 294- 304.
24. Zang, T., Zhuang, L., Zhang, Z., Xin, D. & Guo, Y. (2000). Aberrant activity of Wnt/Frizzled signaling pathway in renal cancer cell lines. Chinese Science Bulletin 45: 1703-1707.
25. Zhu, G., Gilchrist, R., Borley, N., Chng, H.W., Morgan, M., Marshall, J.F., Camplejohn, R.S., Muir, G.H. & Hart, I.R. (2004). Reduction of TSG101 protein has a negative impact on tumor cell growth. International Journal of Cancer 109: 541-547.